Bacillus coagulans is a lactic acid-producing and spore-forming bacterium used in probiotic supplements to promote digestive health. The microbe survives the acidic environment of the stomach. Bacillus coagulans supplements are marketed for uses like controlling diarrhea, improving symptoms of irritable bowel syndrome, maintaining a healthy immune system, and supporting cardiovascular wellness. With rising awareness about gut health and increasing preference for natural remedies, the demand for probiotic supplements containing Bacillus coagulans has witnessed substantial growth in the recent past.
The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the major drivers for the growth of the Bacillus Coagulans market is the increasing demand for probiotic supplements. Probiotics support gut health and immunity. With growing awareness about these benefits, more people are regularly consuming probiotic supplements. Bacillus Coagulans offers advantages like surviving stomach acidity and effectively colonizing the intestines. Supplements containing this strain are considered highly effective. The market has witnessed a surge in new product launches catering to the rising demand. In addition, favorable research validating Bacillus Coagulans health benefits has further augmented its popularity. Moreover, growing instances of gastrointestinal issues and preference for natural remedies for gut-related ailments work in favor of probiotic supplements, fuelling market expansion. However, factors like lack of standardized manufacturing practices and safety concerns associated with bacterial infections may impede the market growth.
SWOT Analysis
Strength: Bacillus Coagulans market is witnessing high demand from probiotic food and beverages industry globally. The probiotic properties of Bacillus Coagulans makes it suitable for developing various functional food and dietary supplement products. Moreover, Bacillus Coagulans is spore forming and can survive the harsh acidic environment of the stomach, providing health benefits.
Weakness: High prices of novel probiotic dietary supplements containing Bacillus Coagulans acts as a barrier for many consumers. Also, lack of research activities especially clinical trials are limitations for the growth of this market.
Opportunity: Rising awareness about digestive and gut health has created growth opportunities for Bacillus Coagulans based products. Growing demand for natural ingredients containing foods and beverages is another key opportunity.
Threats: Presence of substitute probiotic ingredients may threaten the Bacillus Coagulans market. Strict regulatory norms associated with novel food products is a challenge.
Key Takeaways
The Global Bacillus Coagulans Market Size is expected to witness high growth. The market size is anticipated to reach US$ 722.43 Mn in 2023 and expected to grow at a CAGR of 6.8% during the forecast period of 2023 to 2030. Rising health consciousness and increasing consumer preference for functional foods have been driving the demand for probiotic dietary supplements containing Bacillus Coagulans.
Regional analysis
North America dominates the global Bacillus Coagulans market and accounted for around 35% market share in 2022. Robust demand from U.S. due to increasing adoption of probiotic supplements for digestive health and presence of key market players drives the North America Bacillus Coagulans market. Asia Pacific region is anticipated to be the fastest growing market during the forecast period supported by increasing health supplements consumption in large economies like China and India. Rising disposable income and growing willingness to spend on premium health products makes Asia Pacific an important regional market for Bacillus Coagulans.
Key players
Key players operating in the Bacillus Coagulans market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech.
Get More Insights Here
https://www.trendingwebwire.com/bacillus-coagulans-market-size-share-growth-outlook-2023/
The statistical surveying report on the global Bacillus Coagulans Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.
The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.
The statistical data derived from authentic resources and assisted by industry experts.
It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus.
Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary.
Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey’s Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated.
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Bacillus Coagulans market during the historical period of 2013 – 2017.
The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2028, and key prospects over the forecast period 2018 – 2028.Request to View Sample of Report @ https://www.factmr.com/connectus/sample?flag=S_id=2903The Fact.MR report provides key insights on the growth potential of the bacillus coagulans for the forecast period 2018-2028.
According to the report, the bacillus coagulans market is expected to register CAGR of 7.6% in terms of volume between 2018 and 2028.
Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Bacillus Coagulans market, both at global and regional levels.
The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Bacillus Coagulans market.To offer a comprehensive assessment of opportunities, the study makes a scrutiny of growth prospects in various regions.
The key regions comprise the following geographical segments:North AmericaLatin AmericaEuropeJapanAPEJMEAThe detailed assessments focus on, inter alia, on the regulatory and macroeconomic frameworks, prevailing pricing structure, imminent investment pockets, and emerging application areas.
